Publications
Pharmacist intervention acceptance for the reduction of potentially inappropriate drug prescribing in acute psychiatry.
Hannou S, Voirol P, Pannatier A, Weibel ML, Sadeghipour F, von Gunten A, Mall JF, De Giorgi Salamun I
Int J Clin Pharm. 2017 Dec;39(6):1228-1236
Does the type of parenteral lipids matter? A clinical hint in critical illness.
Devaud JC, Berger MM, Pannatier A, Sadeghipour F, Voirol P
Clin Nutr. 2017 Apr;36(2):491-496
Staphylococcus aureus carriage at admission predicts early-onset pneumonia after burn trauma.
Fournier A, Voirol P, Krähenbühl M, Bonnemain CL, Fournier C, Dupuis-Lozeron E, Pantet O, Pagani JL, Revelly JP, Sadeghipour F, Eggimann P, Que YA
Eur J Clin Microbiol Infect Dis. 2017 Mar;36(3):523-528
Massive copper and selenium losses cause life-threatening deficiencies during prolonged continuous renal replacement.
Ben-Hamouda N, Charrière M, Voirol P, Berger MM
Nutrition. 2017 Feb;34:71-75
Biases affecting injected doses of an experimental drug during clinical trials.
Perrottet N, Brunner-Ferber F, Grouzmann E, Spertini F, Biollaz J, Buclin T, Widmer N
Trials. 2016 Jul 16;17(1):321
Antibiotic consumption to detect epidemics of Pseudomonas aeruginosa in a burn centre: A paradigm shift in the epidemiological surveillance of Pseudomonas aeruginosa nosocomial infections.
Fournier A, Voirol P, Krähenbühl M, Bonnemain CL, Fournier C, Pantet O, Pagani JL, Revelly JP, Dupuis-Lozeron E, Sadeghipour F, Pannatier A, Eggimann P, Que YA
Burns. 2016 May;42(3):564-70
A retrospective study of deep sternal wound infections: clinical and microbiological characteristics, treatment, and risk factors for complications.
Chan M, Yusuf E, Giulieri S, Perrottet N, Von Segesser L, Borens O, Trampuz A
Diagn Microbiol Infect Dis. 2016 Mar;84(3):261-5
Antifungal activity against planktonic and biofilm Candida albicans in an experimental model of foreign-body infection.
Maiolo EM, Oliva A, Furustrand Tafin U, Perrotet N, Borens O, Trampuz A
J Infect. 2016 Mar;72(3):386-92
Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis Patients.
Panchaud A, Di Paolo ER, Koutsokera A, Winterfeld U, Weisskopf E, Baud D, Sauty A, Csajka C
Respiration. 2016;91(4):333-48
A bundle with a preformatted medical order sheet and an introductory course to reduce prescription errors in neonates.
Palmero D, Di Paolo ER, Beauport L, Pannatier A, Tolsa JF
Eur J Pediatr. 2016 Jan;175(1):113-9
Mechanisms and Pharmaceutical Consequences of Processes of Stereoisomerisation -- A Didactic Excursion
Testa B., Vistoli G., Pedretti A.
European Journal of Pharmaceutical Sciences 88, 101-123 (2016)
Demonstrating the clinical pharmacist's activity: validation of an intervention oriented classification system.
Maes KA, Tremp RM, GSASA Working group on clinical pharmacy., Hersberger KE, Lampert ML
Int J Clin Pharm. 2015 Dec;37(6):1162-71
Efficacy and safety of high-dose daptomycin (>6 mg/kg) for complicated bone and joint infections and implant-associated infections caused by Gram-positive bacteria.
Perrottet N, Steinrücken J, Chan M, Pannatier A, Borens O, Yusuf E, Trampuz A
Int J Antimicrob Agents. 2015 Oct;46(4):480-2
Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
Fournier A, Eggimann P, Pagani JL, Revelly JP, Decosterd LA, Marchetti O, Pannatier A, Voirol P, Que YA
Burns. 2015 Aug;41(5):956-68
Demonstration of the effectiveness of zinc in diarrhoea of children living in Switzerland.
Crisinel PA, Verga ME, Kouame KS, Pittet A, Rey-Bellet CG, Fontaine O, Di Paolo ER, Gehri M
Eur J Pediatr. 2015 Aug;174(8):1061-7
Stop using the flotation technique and start weighing salbutamol pressurised metered-dose inhalers without dose counters.
Di Paolo ER, Spaggiari S, Pannatier A, Sadeghipour F, Rochat I, Hafen GM
Swiss Med Wkly. 2015;145:w14162
Trace element monitoring in the ICU: quality and economic impact of a change in sampling practice.
Gagnon G, Voirol P, Soguel L, Boulat O, Berger MM
Clin Nutr. 2015 Jun;34(3):422-7
Effective treatment of invasive Aspergillus fumigatus infection using combinations of topical and systemic antifungals in a severely burned patient.
Fournier A, Pantet O, Guerid S, Eggimann P, Pagani JL, Revelly JP, Hauser PM, Marchetti O, Fontanella S, Letovanec I, Ravat F, Berger MM, Pannatier A, Voirol P, Que YA
J Burn Care Res. 2015 Mar-Apr;36(2):e85-9
[Phthalate exposure in the neonatal intensive care unit].
Fischer Fumeaux CJ, Stadelmann Diaw C, Palmero D, M'Madi F, Tolsa JF
Arch Pediatr. 2015 Feb;22(2):203-10
Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
Sidler-Moix AL, Di Paolo ER, Dolci U, Berger-Gryllaki M, Cotting J, Pannatier A
Respir Care. 2015 Jan;60(1):38-46
Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU
Voirol P., Berger-Gryllaki M., Pannatier A., Eggimann P., Sadeghipour F.
Eur J Hosp Pharm, 2015; 22:2 (123-124)
Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection.
Yusuf E, Perrottet N, Orasch C, Borens O, Trampuz A
Surg Infect (Larchmt). 2014 Dec;15(6):834-7
Development of ready-to-use cefuroxime syringes for use in ophthalmology
Fleury-Souverain S., Sadeghipour F. Bonnabry P.
European Journal of Hospital Pharmacy: Science and Practice, 21:1(34-38), 2014
Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU
Voirol P., Berger-Gryllaki M., Pannatier A., Eggimann P., Sadeghipour F.
Eur J Hosp Pharm, DOI 10.1136/ejhpharm-2014-000478
Organisation et sécurisation du circuit des chimiothérapies : Exemple de la pharmacie des Hôpitaux Universitaires de Genève
Carrez L., Falaschi L., Cingria L., Sadeghipour F.
Pharmactuel 2014; 47(2) 119-124
Phthalates in the NICU: is it safe?
Fischer CJ, Bickle Graz M, Muehlethaler V, Palmero D, Tolsa JF
J Paediatr Child Health. 2013 Sep;49(9):E413-9
Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department.
Bez C, Perrottet N, Zingg T, Leung Ki EL, Demartines N, Pannatier A
J Eval Clin Pract. 2013 Apr;19(2):374-8
Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: is there a role for antibiotic diversity?
Plüss-Suard C, Pannatier A, Kronenberg A, Mühlemann K, Zanetti G
Antimicrob Agents Chemother. 2013 Apr;57(4):1709-13
Pediatric drug-related problems: a multicenter study in four French-speaking countries.
Prot-Labarthe S, Di Paolo ER, Lavoie A, Quennery S, Bussières JF, Brion F, Bourdon O
Int J Clin Pharm. 2013 Apr;35(2):251-9
Evolving trends in the costs associated with hospital use of immunosuppressive drugs.
Perrottet N, Aubert V, Venetz JP, Ugolini E, Matter M, Pannatier A, Pascual M
Transplantation. 2013 Mar 15;95(5):e24-5
Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
Sidler-Moix AL, Dolci U, Berger-Gryllaki M, Pannatier A, Cotting J, Di Paolo ER
Pediatr Crit Care Med. 2013 Feb;14(2):e98-102
Détermination d’un indicateur d’activité pertinent pour les préparations en pharmacie hospitalière : comparaison interétablissements de la préparation des chimiothérapies
Malbranche C., Lamon S., Roland I., Jacob D., Duban M., Pernot C
Le pharmacien hospitalier et clinicien, 48 (1), 27-36, 2013
Costs Evaluations of Ready-To-Use Propofol Syringes Versus Syringes Drawn from Vials in Critically Ill
J.C. Devaud, P. Eggimann, P. Voirol, P. Jolliet, C. Pinget, J.B. Wasserfallen, A. Pannatier
Value in Health, 16(7), A323-A636, 2013
In vitro compatibility of various cardioactive drugs during simulated Y-site administration
Humbert-Delaloye V., Berger M., Voirol P., Gattlen L., Pannatier A.
Eur J Hosp Pharm, 20:110-116, 2013, DOI 10.1136/ejhpharm-2012-000239
Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide
Humbert-Delaloye V., Berger-Gryllaki M., Voirol P., Testa B., Pannatier A.
Eur J Hosp Pharm, DOI 10.1136/ejhpharm-2013-000431
Hypertriglyceridemia: a potential side effect of propofol sedation in critical illness.
Devaud JC, Berger MM, Pannatier A, Marques-Vidal P, Tappy L, Rodondi N, Chiolero R, Voirol P
Intensive Care Med. 2012 Dec;38(12):1990-8
Five-year evolution of drug prescribing in a university adult intensive care unit.
Carron C, Voirol P, Eggimann P, Pannatier A, Chioléro R, Wasserfallen JB
Appl Health Econ Health Policy. 2012 Sep 1;10(5):355-8
Role of Phase I Metabolism in Drug Activation and Clinical Treatment Outcomes
Bernard Testa André Pannatier
Encyclopedia of Drug Metabolism and Interactions, 6-Volume Set, First Edition, Chapter 11. Edited by Alexander V. Lyubimov. 2012 John Wiley & Sons, Inc. Published 2012 by John Wiley & Sons, Inc. P. 1-23
A highly sensitive LC-tandem MS assay for the measurement in plasma and in urine of salbutamol administered by nebulization during mechanical ventilation in healthy volunteers.
Sidler-Moix AL, Mercier T, Decosterd LA, Di Paolo ER, Berger-Gryllaki M, Cotting J, Pannatier A
Biomed Chromatogr. 2012 May;26(5):672-80
Outpatient prescriptions practice and writing quality in a paediatric university hospital.
Di Paolo ER, Gehri M, Ouedraogo-Ruchet L, Sibailly G, Lutz N, Pannatier A
Swiss Med Wkly. 2012;142:w13564
Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis.
Plüss-Suard C, Pannatier A, Ruffieux C, Kronenberg A, Mühlemann K, Zanetti G
Antimicrob Agents Chemother. 2012 Feb;56(2):989-94
The hospital pharmacist: an important contributor to improved patient safety in the hospital.
Berthouzoz S, Berger L, Bonnabry P, Pannatier A
Chimia (Aarau). 2012;66(5):300-3
Quels sont les dangers liés à l'utilisation de suppositoires à base d'huiles essentielles chez les petits enfants ?
Di Paolo E.R., Pannatier A., Hafen G.
Paediatrica, 23(4), 35-36, 2012
Proposition d'une marche à suivre pour la gestion et la prévention d'extravasation d'agents non cytotoxiques
Devaud J.-C., Sigrist T., Zaugg C., Guignard B., Pannatier A., Bonnabry P.
Pharmactuel, 45(2), 132-136, 2012
In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs
Humbert-Delaloye V., Berger M., Voirol P., Pannatier A.
European Journal of Hospital Pharmacy, 19:57-64, 2012
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
Manuel O, Perrottet N, Pascual M
Expert Rev Anti Infect Ther. 2011 Nov;9(11):955-65
Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe.
Plüss-Suard C, Pannatier A, Kronenberg A, Mühlemann K, Zanetti G
J Hosp Infect. 2011 Oct;79(2):166-71
Substance P-induced skin inflammation is not modulated by a single dose of sitagliptin in human volunteers.
Grouzmann E, Bigliardi P, Appenzeller M, Pannatier A, Buclin T
Biol Chem. 2011 Mar;392(3):217-21
Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices.
Schneider AG, Perez MH, Tozzi P, Voirol P, Schoettker P, Angelillo-Scherrer A, Cotting J, Von Segesser L, Eggimann P
Intensive Care Med. 2010 Sep;36(9):1620-1
Vincristine and intestinal pseudo-obstruction in children: report of 5 cases, literature review, and suggested management.
Diezi M, Nydegger A, Di Paolo ER, Kuchler H, Beck-Popovic M
J Pediatr Hematol Oncol. 2010 May;32(4):e126-30
Blunting the response to endotoxin in healthy subjects: effects of various doses of intravenous fish oil.
Pittet YK, Berger MM, Pluess TT, Voirol P, Revelly JP, Tappy L, Chioléro RL
Intensive Care Med. 2010 Feb;36(2):289-95
Risk factors for hypertriglyceridemia in the intensive care unit (ICU) : an exploratory study
Devaud J.-C, Voirol P, Marques-Vidal P, Tappy L, Rodondi N, Berger M.M, Chioléro R, Pannatier A.
Critical Care, 14, (Suppl 1), 586, 2010
The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube.
Podilsky G, Berger-Gryllaki M, Testa B, Buclin T, Roulet M, Pannatier A
Eur J Clin Pharmacol. 2009 May;65(5):435-42
Formation et recherche en pharmacie hospitalière et communautaire - état des lieux et perspectives en Suisse romande
Pannatier A, Bugnon O, Csajka Ch, Bonnabry P.
Pharmactuel, 42(1), 53-61, 2009
Marasmus
Rabinowitz S, Gehri M, Di Paolo ER, Wetterer NM
Emedicine, 2009
Utilisation "off label" des médicaments psychotropes (1/2)
Baumann P, Voirol P.
Pharmajournal 22, 7-10, 2009
Utilisation "off label" des médicaments psychotropes (2/2)
Baumann P, Voirol P.
Pharmajournal 23, 8-10, 2009
[Monitoring drug adherence for hypertensive and dyslipidemic patients in networks of community-based pharmacists and physicians].
Santschi V, Rodondi N, Bugnon O, Pannatier A, Burnier M
Rev Med Suisse. 2008 Sep 10;4(170):1928, 1930-2, 1934 passim
Cefuroxime prophylaxis is effective in noninstrumented spine surgery: a double-blind, placebo-controlled study.
Petignat C, Francioli P, Harbarth S, Regli L, Porchet F, Reverdin A, Rilliet B, de Tribolet N, Pannatier A, Pittet D, Zanetti G
Spine (Phila Pa 1976). 2008 Aug 15;33(18):1919-24
Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
Turello R, Rentsch K, Di Paolo E, Popovic MB
Pediatr Blood Cancer. 2008 Jan;50(1):154-6
Food and natural products interactions. Snippets for Snappy Antimicrobial Therapy
Voirol P.
D.J.G Thirion, Publivations PRISM, 229-232, Montréal 2007
Evaluation of intravenous drug compatibilities in an adult intensive care unit.
Humbert-Delaloye V, Testa B, Voirol P, Pannatier A.
Hospital Pharmacy Europe, 32, 56-57, 2007.
Predimed : la prescription médicamenteuse informatisée dans les hôpitaux du canton de Vaud.
Grouzmann MC, Cohen P, Besson P, Clement F, Coppex C, Klopotov A, Meyer PY, Nakov K, Pouly A, Thiebaud C, Pannatier A, Wasserfallen JB.
Swiss Medical Informatics (SMI), 62, 24-28, 2007.
Articles en pdf
2015
- L'intervention pharmaceutique dans une unité de psychiatrie permet de réduire les prescriptions inappropriées / Die pharmazeutische Intervention auf einer psychiatrischen Station erlaubt die Reduktion inadäquater Verschreibungen
Hannou S., Pannatier A., Von Gunten A., Voirol P., Sadeghipour F., Weibel M.-L., Mall J.-F., De Giorgi I. pharmaJournal 02, 1.2015 - Portrait d'Ermindo Di Paolo
Philbet T., Di Paolo ER. pharmaJournal 03, 1.2015
2014
- Compatibilités physico-chimiques: nouvelles données (1, 2) / Physikalisch-chemische Kombatibilität von intravenösen Medikamenten: neue Daten (1, 2)
Humbert-Delaloye V., Pannatier A. pharmaJournal 11, 5.2014 - Organisation et sécurisation du circuit des chimiothérapies : Exemple de la pharmacie des Hôpitaux Universitaires de Genève
Carrez L., Palaschi L., Cingria L., Sadeghipour F., Bouchoud L., Bonnabry P. Pharmactuel, 47(2), 119-124, 2014
2012
- Mischung von Phenhydan® Infusions-konzentrat mit Phenhydan® Injektionslösung
Humbert-Delaloye V., Marty S., Berger-Gryllaki M., Pannatier A. Krankenhauspharmazie, 33:68-72, 2012
2008
- Impact de l'introduction d'une nouvelle pratique de protection des mains au sein d'un site pilote du Centre Hospitalier Universitaire Vaudois.
Maier S, Raselli P, Hirschi B, Pannatier A. Dermatologica Helvetica, 05, 25-26, 2008. - Suivi de l’adhésion thérapeutique des patients hypertendus ou dyslipidémiques par les cercles de qualité médecins-pharmaciens.
Santschi V, Rodondi N, Bugnon O, Pannatier A, Burnier M. Revue Médicale Suisse, 04, 1928-1936, 2008.
2007
- Administration des médicaments chez les patients alimentés par sonde.
Michel C, Di Paolo ER., Podilsky G, Roulet M, Coti Bertrand P. Société Neuchâteloise de Médecine News 2007 n° 55; 19-23. - Development of a stable pediatric oral solution of captopril.
Berger-Gryllaki M, Podilsky G, Widmer N, Gloor S, Testa B, Pannatier A. European Journal of Hospital Pharmacy Science, 13, 67-72, 2007. - Predimed : la prescription médicamenteuse informatisée dans les hôpitaux du canton de Vaud.
Grouzmann MC, Cohen P, Besson P, Clement F, Coppex C, Klopotov A, Meyer PY, Nakov K, Pouly A, Thiebaud C, Pannatier A, Wasserfallen JB. Swiss Medical Informatics (SMI), 62, 24-28, 2007.
CHUV
Rue du Bugnon 46
CH - 1011 Lausanne
+41 21 314 4304
